Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia

Overview

Oropharyngeal dysphagia induces aspirations which could be responsible of aspiration pneumonia and denutrition. It could be present in the majority of central neurological disease (degenerative or vascular disease), which explains that it is the first case of mortality in stroke. Two pilot studies realised by our research group aimed to demonstrate that sensitive transcutaneous electrical stimulation could improve swallowing coordination and reduce aspirations. This technique could be used at home. The aim of this study is to demonstrate that sensitive electrical stimulation could improve oropharyngeal dysphagia in hemispheric stroke patients. 118 patients should be included in seven centers. Sensitive electrical stimulation will be applied either as active stimulation, either as a placebo. Active electrical stimulation will be realised at 80 hz during 30 minutes, under motor threshold and above sensitive threshold. It will be administrated via surface electrodes over the hyoid bone. Patients will be separated by randomisation. Patients will be evaluated before and after 6 weeks of use. Methods will evaluation questionnaire, clinical examination and videofluoroscopy. The time of use will also be collected. We wish to demonstrate that transcutaneous electrical stimulation is able to improve oropharyngeal dysphagia in stroke.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Participant)
  • Study Primary Completion Date: May 2016

Interventions

  • Device: Urostim I stimulation
    • Urostim I stimulation will be done during meals for 6 weeks

Arms, Groups and Cohorts

  • Experimental: active stimulation
    • sensitive electrical stimulation applied during meals with Urostim I for 6 weeks Urostim I stimulation will be done during meals for 6 weeks
  • Placebo Comparator: fake stimulation
    • Urostim I stimulation will be done during meals for 6 weeks Fake sensitive electrical stimulation applied during meals with modified Urostim I who not deliver stimulation for 6 weeks

Clinical Trial Outcome Measures

Primary Measures

  • Evaluation of oropharyngeal dysphagia symptoms
    • Time Frame: Week 6
    • Evaluation of oropharyngeal dysphagia symptoms by questionnaire (dysphagia handicap index)

Secondary Measures

  • Evaluation of oropharyngeal dysphagia symptoms
    • Time Frame: Week 6
    • Evaluation of oropharyngeal dysphagia symptoms by videofluoroscopy and Swal-QoL questionnaire

Participating in This Clinical Trial

Inclusion Criteria

  • Age between 18 and 85 years – No contraindication to electrical stimulation – Oropharyngeal dysphagia from 8 weeks diagnosed by videofluorosocpy with penetration aspiration scale > 3 or a residue ≥ 50% – Due to an hemispheric stroke – Patients able to understand the videofluroscopy and questionnaires – For women in age of procreation, to have a contraception, a pregnacy test will be done if not – Able to swallow (a nasogastric tube is not a contraindication to participate) Exclusion Criteria:

  • Pregnancy or breast feeding – Psychiatric illnes – Swallowing disorders before the stroke – Contraindication to electrical stimulation

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 85 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Rouen
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Eric VERIN, Professor, Principal Investigator, UH Rouen

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.